Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PF-00610355

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background and ObjectivesPF-00610355 is an orally inhaled long-acting β2-adrenoreceptor agonist that is being developed for the… Expand
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
2013
2013
AIM To assess the cardiovascular effects of a new inhaled long-acting β-adrenoceptor agonist PF-00610355 in COPD patients… Expand
2012
2012
The objective of this work was to characterize the dose–response relationship between two inhaled long-acting beta agonists (PF… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2010
Review
2010
Purpose of review Because of the central role of bronchodilators in the treatment of asthma, in recent years there has been a… Expand